Accumulating studies in neurological diseases spinal cord injury (SCI) and multiple sclerosis (MS) demonstrate that increased expression of RGMa inhibits axon regeneration and functional recovery in the injured CNS3–6. This evidence concerns the gene RGMA and myeloid sarcoma.